Development and validation of a population-based risk stratification model for severe COVID-19 in the general population.

ABSTRACT: The shortage of recently approved vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the need for evidence-based tools to prioritize healthcare resources for people at higher risk of severe coronavirus disease (COVID-19). Although age has been identified as the most important risk factor (particularly for mortality), the contribution of underlying comorbidities is often assessed using a pre-defined list of chronic conditions. Furthermore, the count of individual risk factors has limited applicability to population-based "stratify-and-shield" strategies. We aimed to develop and validate a COVID-19 risk stratification system that allows allocating individuals of the general population into four mutually-exclusive risk categories based on multiva

SUBMITTER: Vela E 

PROVIDER: S-EPMC8885698 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature